- Lower volatility than the market (beta 0.41)
- Highly efficient cash conversion (100% FCF/OCF ratio)
- +24.3% price growth over the last year
Immuneering Corporation stock price up more than 8.43% on Wednesday
(Updated on Jul 08, 2026)
The Immuneering Corporation stock price gained 8.43% on the last trading day (Wednesday, 8th Jul 2026), rising from $5.10 to $5.53. During the last trading day the stock fluctuated 9.11% from a day low at $5.10 to a day high of $5.56. The price has risen in 6 of the last 10 days and is up by 21.81% over the past 2 weeks. Volume has increased on the last day along with the price, which is a positive technical sign, and, in total, 582 thousand more shares were traded than the day before. In total, 2 million shares were bought and sold for approximately $8.75 million.
Given the current short-term trend, the stock is expected to fall -18.02% during the next 3 months and, with a 90% probability hold a price between $2.92 and $4.53 at the end of this 3-month period. Do note, that if the stock price manages to stay at current levels or higher, our prediction target will start to change positively over the next few days as the conditions for the current predictions will be broken.
IMRX Signals & Forecast
Mostly positive signals in the chart today. The Immuneering Corporation stock holds buy signals from both short and long-term Moving Averages giving a positive forecast for the stock. Also, there is a general buy signal from the relation between the two signals where the short-term average is above the long-term average. On corrections down, there will be some support from the lines at $5.15 and $4.72. A breakdown below any of these levels will issue sell signals. A buy signal was issued from a pivot bottom point on Wednesday, June 10, 2026, and so far it has risen 41.07%. Further rise is indicated until a new top pivot has been found. Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Volume is rising along with the price. This is considered to be a good technical signal.
Support, Risk & Stop-loss for Immuneering Corporation stock
Immuneering Corporation finds support from accumulated volume at $5.39 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
This stock may move much during the day (volatility) and with a large prediction interval from the Bollinger Band this stock is considered to be "high risk". During the last day, the stock moved $0.464 between high and low, or 9.11%. For the last week, the stock has had daily average volatility of 5.58%.
The Immuneering Corporation stock is overbought on RSI14 and lies in the upper part of the trend. Normally this may pose a good selling opportunity for the short-term trader, but some stocks may go long and hard while being overbought. Regardless, the high RSI together with the trend position increases the risk and higher daily movements (volatility) should be expected. A correction down in the nearby future seems very likely and it is of great importance that the stock manages to break the trend before that occurs.
Our recommended stop-loss: $5.33 (-3.60%) (This stock has high daily movements and this gives high risk. The RSI14 is 88 and this increases the risk substantially. There is a buy signal from a pivot bottom found 18 days ago.)
Trading Expectations (IMRX) For The Upcoming Trading Day Of Thursday 9th
For the upcoming trading day on Thursday, 9th we expect Immuneering Corporation to open at $5.40, and during the day (based on 14 day Average True Range), to move between $5.37 and $5.69, which gives a possible trading interval of +/-$0.327 (+/-6.09%) up or down from last closing price. If Immuneering Corporation takes out the full calculated possible swing range there will be an estimated 6.09% move between the lowest and the highest trading price during the day.
Since the stock is closer to the resistance from accumulated volume at $5.57 (0.72%) than the support at $5.39 (2.53%), our systems don't find the trading risk/reward intra-day attractive and any bets should be held until the stock is closer to the support level.
Is Immuneering Corporation stock A Buy?
Several short-term signals are positive, despite the stock being in a falling trend, we conclude that the current level may hold a buying opportunity as there is a fair chance for stock to perform well in the short-term. We have upgraded our analysis conclusion for this stock since the last evaluation from a Hold to a Buy candidate.
Current score:
4.969
Buy Candidate
Upgraded
Predicted Fair Opening Price
Predicted fair opening price on July 9, 2026 - $5.40 ( 2.44%).
Want to trade but not sure how?
Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* 
*Your capital is at risk
IMRX Performance
Trading levels for IMRX
Fibonacci Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 5.86 | 5.96% |
| R2 | 5.68 | 2.75% |
| R1 | 5.57 | 0.770% |
| Price | 5.53 | |
| S1 | 5.22 | -5.64% |
| S2 | 5.11 | -7.62% |
| S3 | 4.93 | -10.83% |
Accumulated Volume Support & Resistance Levels
| Level | Price | |
|---|---|---|
| R3 | 6.13 | 10.85% |
| R2 | 5.77 | 4.34% |
| R1 | 5.57 | 0.723% |
| Price | 5.53 | |
| S1 | 5.39 | -2.53% |
| S2 | 4.76 | -13.92% |
| S3 | 4.50 | -18.72% |
FAQ
Click here for our free guide on how to buy Immuneering Corporation Stock.
Buy IMRX